Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leukemia, Myelogenous, Chronic Phase”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT03560752
What this trial is testing

CMV-MVA Triplex Vaccination of Stem Cell Donors in Preventing CMV Viremia in Participants With Allogeneic Transplant

Who this might be right for
Accelerated Phase CML, BCR-ABL1 PositiveAcute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia in Remission+11 more
City of Hope Medical Center 34
Early research (Phase 1)Study completedNCT00890747
What this trial is testing

Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAcute Undifferentiated Leukemia+82 more
National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Ended earlyNCT01570868
What this trial is testing

Ponatinib - Frontline for Chronic Myeloid Leukemia (CML) in Accelerated Phase (AP)

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 51
Testing effectiveness (Phase 2)Active Not RecruitingNCT02689440
What this trial is testing

Dasatinib and Venetoclax in Treating Patients With Philadelphia Chromosome Positive or BCR-ABL1 Positive Early Chronic Phase Chronic Myelogenous Leukemia

Who this might be right for
Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositivePhiladelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia
M.D. Anderson Cancer Center 155
Testing effectiveness (Phase 2)Study completedNCT00481052
What this trial is testing

Nilotinib as First-line Treatment of Ph+ CML in Early Chronic Phase

Who this might be right for
Chronic Myeloid Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 74
Testing effectiveness (Phase 2)Ended earlyNCT03593915
What this trial is testing

A Phase 1b/2 Study of Alvocidib Plus Decitabine or Azacitidine in Patients With MDS

Who this might be right for
Myelodysplastic Syndromes (MDS)
Sumitomo Pharma America, Inc. 20
Testing effectiveness (Phase 2)UnknownNCT03348033
What this trial is testing

Safety and Feasibility of the Use of Natural Killer Cells in Patients With Chronic Myeloid Leukemia

Who this might be right for
Chronic Myeloid Leukemia
Hospital de Clinicas de Porto Alegre 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT03906292
What this trial is testing

Frontline Asciminib Combination in Chronic Phase CML

Who this might be right for
Chronic Myeloid Leukemia
University of Jena 125
Early research (Phase 1)Active Not RecruitingNCT04980404
What this trial is testing

Inqovi Maintenance Therapy in Myeloid Neoplasms

Who this might be right for
Myelodysplastic SyndromesChronic Myelomonocytic LeukemiaStem Cell Leukemia
Massachusetts General Hospital 22
Early research (Phase 1)Study completedNCT01677780
What this trial is testing

An Extension Study of RO5045337 in Participants Participating in Previous Roche-sponsored Cancer Studies

Who this might be right for
Myelogenous Leukemia, Chronic, Neoplasms, Myelogenous Leukemia, Acute
Hoffmann-La Roche 11
Testing effectiveness (Phase 2)Study completedNCT00027924
What this trial is testing

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT00118196
What this trial is testing

Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Medical University of South Carolina 1
Early research (Phase 1)Study completedNCT00003079
What this trial is testing

Bryostatin 1 and High Dose Cytarabine in Treating Patients With Refractory or Relapsed Leukemia or Lymphoma

Who this might be right for
LeukemiaLymphoma
Virginia Commonwealth University 30
Testing effectiveness (Phase 2)Study completedNCT01621724
What this trial is testing

WT1 TCR Gene Therapy for Leukaemia: A Phase I/II Safety and Toxicity Study

Who this might be right for
Acute Myeloid LeukaemiaChronic Myeloid Leukaemia
Cell Medica Ltd 7
Not applicableEnded earlyNCT00900068
What this trial is testing

Blood Samples From Patients on a Clinical Trial to CINV During HSCT

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
OHSU Knight Cancer Institute 9
Not applicableNo Longer AvailableNCT00423826
What this trial is testing

Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+3 more
Barbara Ann Karmanos Cancer Institute
Early research (Phase 1)Study completedNCT00331513
What this trial is testing

Vorinostat and Idarubicin in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndromes

Who this might be right for
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)+12 more
National Cancer Institute (NCI) 40
Early research (Phase 1)Study completedNCT00015925
What this trial is testing

MS-275 in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic Syndromes+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)WithdrawnNCT00002790
What this trial is testing

Prevention of Graft-Versus-Host Disease in Patients With Hematologic Malignancies Who Are Receiving a Bone Marrow Transplant

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00298987
What this trial is testing

Dasatinib in Patients With Chronic Myelogenous Leukemia Who Are Resistant or Intolerant of Imatinib Mesylate

Who this might be right for
Leukemia, Myeloid, ChronicLeukemia, Lymphocytic, Acute, L2
Bristol-Myers Squibb 400
Next Page